FDA’s Breakthrough Therapy Designation Program

The FDA Division of Drug Information’s next webinar, An Overview of the FDA’s Breakthrough Therapy Designation Program, is scheduled for Tuesday, December 1st at 1 p.m. (ET).

This webinar will discuss the July 9, 2012, Food and Drug Safety and Innovation Act (FDASIA) 902 Breakthrough Designation Provision and the impact it has on patients living with serious and life-threatening conditions for which there are limited available therapies. This session will be of interest to students and health care providers who want to become familiar with this expedited drug development and review pathway that helps to bring promising new drugs to market in an expeditious manner.

Register now for this free webinar. Click here to find a complete list of past and scheduled webinars.